The latest price target for Yield10 Bioscience (OTCQB:YTEN) was reported by Lake Street on February 8, 2024. The analyst firm set a price target for $0.50 expecting YTEN to fall to within 12 months (a possible -54.55% downside). 3 analyst firms have reported ratings in the last year.

The latest analyst rating for Yield10 Bioscience (OTCQB:YTEN) was provided by Lake Street, and Yield10 Bioscience downgraded their hold rating.

There is no last upgrade for Yield10 Bioscience

The last downgrade for Yield10 Bioscience Inc happened on February 8, 2024 when Lake Street changed their price target from N/A to $0.5 for Yield10 Bioscience Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Yield10 Bioscience, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Yield10 Bioscience was filed on February 8, 2024 so you should expect the next rating to be made available sometime around February 8, 2025.

While ratings are subjective and will change, the latest Yield10 Bioscience (YTEN) rating was a downgraded with a price target of $0.00 to $0.50. The current price Yield10 Bioscience (YTEN) is trading at is $1.10, which is out of the analyst’s predicted range.